 | • レポートコード：MRC23Q35783 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、113ページ • 納品方法：Eメール（2-3日） • 産業分類：医療 |
| Single User | ￥435,000 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥870,000 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界の抗体開発サービス市場について調査・分析し、世界の抗体開発サービス市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（モノクローナル抗体開発、ポリクローナル抗体開発）、用途別セグメント分析（医療産業、バイオ産業、その他）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、Thermo Fisher Scientific、R&D Systems、Leinco Technologies、Rockland Immunochemicals, Inc. (Rockland)、Bio-Rad、BioGenes、ProteoGenix、Labcorp、Inotiv, Inc.、ProMab Biotechnologies、Kemp Proteins、Synaptic Systems、ARVYS Proteins, Inc.、BBI Solutions、Innovagen AB、BIOTEM、Medimab、OriGene、Abeomics Inc.、RayBiotech、Genscript Biotech Corporation、Sino Biological、Abzena Ltd、Creative Biolabs、Abcam、Antibodies Incorporatedなどが含まれています。世界の抗体開発サービス市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、抗体開発サービス市場規模を推定する際に考慮しました。本レポートは、抗体開発サービスの世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、抗体開発サービスに関するビジネス上の意思決定に役立てることを目的としています。 ・抗体開発サービス市場の概要 - 抗体開発サービスのタイプ別セグメント - 世界の抗体開発サービス市場規模：タイプ別分析（モノクローナル抗体開発、ポリクローナル抗体開発） - 抗体開発サービスの用途別セグメント - 世界の抗体開発サービス市場規模：用途別分析（医療産業、バイオ産業、その他） - 世界の抗体開発サービス市場規模予測（2018年-2029年） ・抗体開発サービス市場の成長トレンド - 抗体開発サービスの地域別市場規模（2018年-2029年） - 抗体開発サービス市場ダイナミクス - 抗体開発サービスの業界動向 - 抗体開発サービス市場の成長ドライバ、課題、阻害要因 ・主要企業別競争状況 - 企業別市場シェア - 世界の主要企業、業界ランキング分析 - 市場への参入、M＆A動向 ・タイプ別セグメント：モノクローナル抗体開発、ポリクローナル抗体開発 - 世界の抗体開発サービスのタイプ別市場規模（2018年-2023年） - 世界の抗体開発サービスのタイプ別市場規模（2024年-2029年） ・用途別セグメント：医療産業、バイオ産業、その他 - 世界の抗体開発サービスの用途別市場規模（2018年-2023年） - 世界の抗体開発サービスの用途別市場規模（2024年-2029年） ・抗体開発サービスの地域別市場規模 - 北米の抗体開発サービス市場規模（2018年-2029年） - アメリカの抗体開発サービス市場規模（2018年-2029年） - ヨーロッパの抗体開発サービス市場規模（2018年-2029年） - アジア太平洋の抗体開発サービス市場規模（2018年-2029年） - 中国の抗体開発サービス市場規模（2018年-2029年） - 日本の抗体開発サービス市場規模（2018年-2029年） - 韓国の抗体開発サービス市場規模（2018年-2029年） - インドの抗体開発サービス市場規模（2018年-2029年） - オーストラリアの抗体開発サービス市場規模（2018年-2029年） - 中南米の抗体開発サービス市場規模（2018年-2029年） - 中東・アフリカの抗体開発サービス市場規模（2018年-2029年） ・主要企業のプロファイル：企業情報、事業概要、売上、動向 Thermo Fisher Scientific、R&D Systems、Leinco Technologies、Rockland Immunochemicals, Inc. (Rockland)、Bio-Rad、BioGenes、ProteoGenix、Labcorp、Inotiv, Inc.、ProMab Biotechnologies、Kemp Proteins、Synaptic Systems、ARVYS Proteins, Inc.、BBI Solutions、Innovagen AB、BIOTEM、Medimab、OriGene、Abeomics Inc.、RayBiotech、Genscript Biotech Corporation、Sino Biological、Abzena Ltd、Creative Biolabs、Abcam、Antibodies Incorporated ・アナリストの観点/結論 ・調査方法とデータソース |
Highlights
The global Antibody Development Services market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Antibody Development Services is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Antibody Development Services is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Antibody Development Services in Medical Industry is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Antibody Development Services include Thermo Fisher Scientific, R&D Systems, Leinco Technologies, Rockland Immunochemicals, Inc. (Rockland), Bio-Rad, BioGenes, ProteoGenix, Labcorp and Inotiv, Inc., etc. In 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Antibody Development Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antibody Development Services.
The Antibody Development Services market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Antibody Development Services market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antibody Development Services companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Thermo Fisher Scientific
R&D Systems
Leinco Technologies
Rockland Immunochemicals, Inc. (Rockland)
Bio-Rad
BioGenes
ProteoGenix
Labcorp
Inotiv, Inc.
ProMab Biotechnologies
Kemp Proteins
Synaptic Systems
ARVYS Proteins, Inc.
BBI Solutions
Innovagen AB
BIOTEM
Medimab
OriGene
Abeomics Inc.
RayBiotech
Genscript Biotech Corporation
Sino Biological
Abzena Ltd
Creative Biolabs
Abcam
Antibodies Incorporated
Segment by Type
Monoclonal Antibody Development
Polyclonal Antibody Development
Segment by Application
Medical Industry
Biological Industry
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Antibody Development Services companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Antibody Development Services Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Monoclonal Antibody Development
1.2.3 Polyclonal Antibody Development
1.3 Market by Application
1.3.1 Global Antibody Development Services Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Medical Industry
1.3.3 Biological Industry
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Antibody Development Services Market Perspective (2018-2029)
2.2 Antibody Development Services Growth Trends by Region
2.2.1 Global Antibody Development Services Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Antibody Development Services Historic Market Size by Region (2018-2023)
2.2.3 Antibody Development Services Forecasted Market Size by Region (2024-2029)
2.3 Antibody Development Services Market Dynamics
2.3.1 Antibody Development Services Industry Trends
2.3.2 Antibody Development Services Market Drivers
2.3.3 Antibody Development Services Market Challenges
2.3.4 Antibody Development Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Antibody Development Services Players by Revenue
3.1.1 Global Top Antibody Development Services Players by Revenue (2018-2023)
3.1.2 Global Antibody Development Services Revenue Market Share by Players (2018-2023)
3.2 Global Antibody Development Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Antibody Development Services Revenue
3.4 Global Antibody Development Services Market Concentration Ratio
3.4.1 Global Antibody Development Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Antibody Development Services Revenue in 2022
3.5 Antibody Development Services Key Players Head office and Area Served
3.6 Key Players Antibody Development Services Product Solution and Service
3.7 Date of Enter into Antibody Development Services Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Antibody Development Services Breakdown Data by Type
4.1 Global Antibody Development Services Historic Market Size by Type (2018-2023)
4.2 Global Antibody Development Services Forecasted Market Size by Type (2024-2029)
5 Antibody Development Services Breakdown Data by Application
5.1 Global Antibody Development Services Historic Market Size by Application (2018-2023)
5.2 Global Antibody Development Services Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Antibody Development Services Market Size (2018-2029)
6.2 North America Antibody Development Services Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Antibody Development Services Market Size by Country (2018-2023)
6.4 North America Antibody Development Services Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Antibody Development Services Market Size (2018-2029)
7.2 Europe Antibody Development Services Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Antibody Development Services Market Size by Country (2018-2023)
7.4 Europe Antibody Development Services Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Antibody Development Services Market Size (2018-2029)
8.2 Asia-Pacific Antibody Development Services Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Antibody Development Services Market Size by Region (2018-2023)
8.4 Asia-Pacific Antibody Development Services Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Antibody Development Services Market Size (2018-2029)
9.2 Latin America Antibody Development Services Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Antibody Development Services Market Size by Country (2018-2023)
9.4 Latin America Antibody Development Services Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Antibody Development Services Market Size (2018-2029)
10.2 Middle East & Africa Antibody Development Services Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Antibody Development Services Market Size by Country (2018-2023)
10.4 Middle East & Africa Antibody Development Services Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Detail
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Antibody Development Services Introduction
11.1.4 Thermo Fisher Scientific Revenue in Antibody Development Services Business (2018-2023)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 R&D Systems
11.2.1 R&D Systems Company Detail
11.2.2 R&D Systems Business Overview
11.2.3 R&D Systems Antibody Development Services Introduction
11.2.4 R&D Systems Revenue in Antibody Development Services Business (2018-2023)
11.2.5 R&D Systems Recent Development
11.3 Leinco Technologies
11.3.1 Leinco Technologies Company Detail
11.3.2 Leinco Technologies Business Overview
11.3.3 Leinco Technologies Antibody Development Services Introduction
11.3.4 Leinco Technologies Revenue in Antibody Development Services Business (2018-2023)
11.3.5 Leinco Technologies Recent Development
11.4 Rockland Immunochemicals, Inc. (Rockland)
11.4.1 Rockland Immunochemicals, Inc. (Rockland) Company Detail
11.4.2 Rockland Immunochemicals, Inc. (Rockland) Business Overview
11.4.3 Rockland Immunochemicals, Inc. (Rockland) Antibody Development Services Introduction
11.4.4 Rockland Immunochemicals, Inc. (Rockland) Revenue in Antibody Development Services Business (2018-2023)
11.4.5 Rockland Immunochemicals, Inc. (Rockland) Recent Development
11.5 Bio-Rad
11.5.1 Bio-Rad Company Detail
11.5.2 Bio-Rad Business Overview
11.5.3 Bio-Rad Antibody Development Services Introduction
11.5.4 Bio-Rad Revenue in Antibody Development Services Business (2018-2023)
11.5.5 Bio-Rad Recent Development
11.6 BioGenes
11.6.1 BioGenes Company Detail
11.6.2 BioGenes Business Overview
11.6.3 BioGenes Antibody Development Services Introduction
11.6.4 BioGenes Revenue in Antibody Development Services Business (2018-2023)
11.6.5 BioGenes Recent Development
11.7 ProteoGenix
11.7.1 ProteoGenix Company Detail
11.7.2 ProteoGenix Business Overview
11.7.3 ProteoGenix Antibody Development Services Introduction
11.7.4 ProteoGenix Revenue in Antibody Development Services Business (2018-2023)
11.7.5 ProteoGenix Recent Development
11.8 Labcorp
11.8.1 Labcorp Company Detail
11.8.2 Labcorp Business Overview
11.8.3 Labcorp Antibody Development Services Introduction
11.8.4 Labcorp Revenue in Antibody Development Services Business (2018-2023)
11.8.5 Labcorp Recent Development
11.9 Inotiv, Inc.
11.9.1 Inotiv, Inc. Company Detail
11.9.2 Inotiv, Inc. Business Overview
11.9.3 Inotiv, Inc. Antibody Development Services Introduction
11.9.4 Inotiv, Inc. Revenue in Antibody Development Services Business (2018-2023)
11.9.5 Inotiv, Inc. Recent Development
11.10 ProMab Biotechnologies
11.10.1 ProMab Biotechnologies Company Detail
11.10.2 ProMab Biotechnologies Business Overview
11.10.3 ProMab Biotechnologies Antibody Development Services Introduction
11.10.4 ProMab Biotechnologies Revenue in Antibody Development Services Business (2018-2023)
11.10.5 ProMab Biotechnologies Recent Development
11.11 Kemp Proteins
11.11.1 Kemp Proteins Company Detail
11.11.2 Kemp Proteins Business Overview
11.11.3 Kemp Proteins Antibody Development Services Introduction
11.11.4 Kemp Proteins Revenue in Antibody Development Services Business (2018-2023)
11.11.5 Kemp Proteins Recent Development
11.12 Synaptic Systems
11.12.1 Synaptic Systems Company Detail
11.12.2 Synaptic Systems Business Overview
11.12.3 Synaptic Systems Antibody Development Services Introduction
11.12.4 Synaptic Systems Revenue in Antibody Development Services Business (2018-2023)
11.12.5 Synaptic Systems Recent Development
11.13 ARVYS Proteins, Inc.
11.13.1 ARVYS Proteins, Inc. Company Detail
11.13.2 ARVYS Proteins, Inc. Business Overview
11.13.3 ARVYS Proteins, Inc. Antibody Development Services Introduction
11.13.4 ARVYS Proteins, Inc. Revenue in Antibody Development Services Business (2018-2023)
11.13.5 ARVYS Proteins, Inc. Recent Development
11.14 BBI Solutions
11.14.1 BBI Solutions Company Detail
11.14.2 BBI Solutions Business Overview
11.14.3 BBI Solutions Antibody Development Services Introduction
11.14.4 BBI Solutions Revenue in Antibody Development Services Business (2018-2023)
11.14.5 BBI Solutions Recent Development
11.15 Innovagen AB
11.15.1 Innovagen AB Company Detail
11.15.2 Innovagen AB Business Overview
11.15.3 Innovagen AB Antibody Development Services Introduction
11.15.4 Innovagen AB Revenue in Antibody Development Services Business (2018-2023)
11.15.5 Innovagen AB Recent Development
11.16 BIOTEM
11.16.1 BIOTEM Company Detail
11.16.2 BIOTEM Business Overview
11.16.3 BIOTEM Antibody Development Services Introduction
11.16.4 BIOTEM Revenue in Antibody Development Services Business (2018-2023)
11.16.5 BIOTEM Recent Development
11.17 Medimab
11.17.1 Medimab Company Detail
11.17.2 Medimab Business Overview
11.17.3 Medimab Antibody Development Services Introduction
11.17.4 Medimab Revenue in Antibody Development Services Business (2018-2023)
11.17.5 Medimab Recent Development
11.18 OriGene
11.18.1 OriGene Company Detail
11.18.2 OriGene Business Overview
11.18.3 OriGene Antibody Development Services Introduction
11.18.4 OriGene Revenue in Antibody Development Services Business (2018-2023)
11.18.5 OriGene Recent Development
11.19 Abeomics Inc.
11.19.1 Abeomics Inc. Company Detail
11.19.2 Abeomics Inc. Business Overview
11.19.3 Abeomics Inc. Antibody Development Services Introduction
11.19.4 Abeomics Inc. Revenue in Antibody Development Services Business (2018-2023)
11.19.5 Abeomics Inc. Recent Development
11.20 RayBiotech
11.20.1 RayBiotech Company Detail
11.20.2 RayBiotech Business Overview
11.20.3 RayBiotech Antibody Development Services Introduction
11.20.4 RayBiotech Revenue in Antibody Development Services Business (2018-2023)
11.20.5 RayBiotech Recent Development
11.21 Genscript Biotech Corporation
11.21.1 Genscript Biotech Corporation Company Detail
11.21.2 Genscript Biotech Corporation Business Overview
11.21.3 Genscript Biotech Corporation Antibody Development Services Introduction
11.21.4 Genscript Biotech Corporation Revenue in Antibody Development Services Business (2018-2023)
11.21.5 Genscript Biotech Corporation Recent Development
11.22 Sino Biological
11.22.1 Sino Biological Company Detail
11.22.2 Sino Biological Business Overview
11.22.3 Sino Biological Antibody Development Services Introduction
11.22.4 Sino Biological Revenue in Antibody Development Services Business (2018-2023)
11.22.5 Sino Biological Recent Development
11.23 Abzena Ltd
11.23.1 Abzena Ltd Company Detail
11.23.2 Abzena Ltd Business Overview
11.23.3 Abzena Ltd Antibody Development Services Introduction
11.23.4 Abzena Ltd Revenue in Antibody Development Services Business (2018-2023)
11.23.5 Abzena Ltd Recent Development
11.24 Creative Biolabs
11.24.1 Creative Biolabs Company Detail
11.24.2 Creative Biolabs Business Overview
11.24.3 Creative Biolabs Antibody Development Services Introduction
11.24.4 Creative Biolabs Revenue in Antibody Development Services Business (2018-2023)
11.24.5 Creative Biolabs Recent Development
11.25 Abcam
11.25.1 Abcam Company Detail
11.25.2 Abcam Business Overview
11.25.3 Abcam Antibody Development Services Introduction
11.25.4 Abcam Revenue in Antibody Development Services Business (2018-2023)
11.25.5 Abcam Recent Development
11.26 Antibodies Incorporated
11.26.1 Antibodies Incorporated Company Detail
11.26.2 Antibodies Incorporated Business Overview
11.26.3 Antibodies Incorporated Antibody Development Services Introduction
11.26.4 Antibodies Incorporated Revenue in Antibody Development Services Business (2018-2023)
11.26.5 Antibodies Incorporated Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details